526 related articles for article (PubMed ID: 31993782)
1. Crescentic IgA nephropathy in children.
Shima Y; Nakanishi K; Hama T; Mukaiyama H; Sato M; Tanaka Y; Tanaka R; Kaito H; Nozu K; Sako M; Iijima K; Yoshikawa N
Pediatr Nephrol; 2020 Jun; 35(6):1005-1014. PubMed ID: 31993782
[TBL] [Abstract][Full Text] [Related]
2. Clinical course of Immunoglobulin A nephropathy with crescents in a multi-ethnic Southeast Asian cohort.
Lim CC; Baikunje S; Choo JCJ; Tan PH; Foo M; Woo KT
Nephrology (Carlton); 2020 Sep; 25(9):708-713. PubMed ID: 32400945
[TBL] [Abstract][Full Text] [Related]
3. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
[TBL] [Abstract][Full Text] [Related]
4. The correlation analysis between the Oxford classification of Chinese IgA nephropathy children and renal outcome - a retrospective cohort study.
Wu H; Xia Z; Gao C; Zhang P; Yang X; Wang R; Wang M; Peng Y
BMC Nephrol; 2020 Jul; 21(1):247. PubMed ID: 32611399
[TBL] [Abstract][Full Text] [Related]
5. [Clinicopathological analysis of IgA nephropathy with crescentic formation in childhood].
Yao Y; Liu JC; Xiao HJ; Huang JP; Yang JY
Zhonghua Er Ke Za Zhi; 2004 Jun; 42(6):412-6. PubMed ID: 15265422
[TBL] [Abstract][Full Text] [Related]
6. IgA nephropathy with presentation of nephrotic syndrome at onset in children.
Shima Y; Nakanishi K; Sato M; Hama T; Mukaiyama H; Togawa H; Tanaka R; Nozu K; Sako M; Iijima K; Suzuki H; Yoshikawa N
Pediatr Nephrol; 2017 Mar; 32(3):457-465. PubMed ID: 27714465
[TBL] [Abstract][Full Text] [Related]
7. Reversal of active glomerular lesions after immunosuppressive therapy in patients with IgA nephropathy: a repeat-biopsy based observation.
Shen XH; Liang SS; Chen HM; Le WB; Jiang S; Zeng CH; Zhou ML; Zhang HT; Liu ZH
J Nephrol; 2015 Aug; 28(4):441-9. PubMed ID: 25585823
[TBL] [Abstract][Full Text] [Related]
8. Clinical and histological differences between adults and children in new onset IgA nephropathy.
Cambier A; Rabant M; El Karoui K; Peuchmaur M; Servais A; Hertig A; Deschenes G; Salomon R; Hogan J; Robert T
Pediatr Nephrol; 2020 Oct; 35(10):1897-1905. PubMed ID: 32444925
[TBL] [Abstract][Full Text] [Related]
9. A Rare Presentation of Immunoglobulin A Nephropathy: Acute Kidney Injury.
Oruc M; Durak H; Yalin SF; Seyahi N; Altıparmak MR; Trabulus S
Nephron; 2017; 137(1):8-14. PubMed ID: 28743127
[TBL] [Abstract][Full Text] [Related]
10. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients.
Chai L; Cai K; Wang K; Luo Q
J Clin Lab Anal; 2021 Jun; 35(6):e23774. PubMed ID: 33951240
[TBL] [Abstract][Full Text] [Related]
11. IgA Nephropathy with Crescents: A Single-Center Experience.
Ramani N; Whittier WL; Korbet SM
Am J Nephrol; 2022; 53(11-12):786-793. PubMed ID: 36630925
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and pathological analysis of IgA nephropathy with acute kidney injury].
Chen MG; Ye XH; Liang HY; Yang Q
Zhonghua Er Ke Za Zhi; 2016 Aug; 54(8):610-3. PubMed ID: 27510875
[TBL] [Abstract][Full Text] [Related]
13. Volume of Crescents Affects Prognosis of IgA Nephropathy in Patients without Obvious Chronic Renal Pathology.
Lin Z; Liu L; Zhang R; Lin X; Lu F; Bao K; Wang L; Lin Q; Mai J; Cao Y; Yang H; Liu X; Zou C
Am J Nephrol; 2021; 52(6):507-518. PubMed ID: 34134110
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of corticosteroids in immunoglobulin A nephropathy with less than 25% crescents.
Chen J; Xu H; Peng Z; Lin L; Li C; Zhu X; Liu S
Clin Exp Nephrol; 2020 Jan; 24(1):73-81. PubMed ID: 31605314
[TBL] [Abstract][Full Text] [Related]
15. Clinical implication of crescentic lesions in immunoglobulin A nephropathy.
Lee MJ; Kim SJ; Oh HJ; Ko KI; Koo HM; Kim CH; Doh FM; Yoo TH; Kang SW; Choi KH; Lim BJ; Jeong HJ; Han SH
Nephrol Dial Transplant; 2014 Feb; 29(2):356-64. PubMed ID: 24081867
[TBL] [Abstract][Full Text] [Related]
16. A histologic classification of IgA nephropathy for predicting long-term prognosis: emphasis on end-stage renal disease.
Kawamura T; Joh K; Okonogi H; Koike K; Utsunomiya Y; Miyazaki Y; Matsushima M; Yoshimura M; Horikoshi S; Suzuki Y; Furusu A; Yasuda T; Shirai S; Shibata T; Endoh M; Hattori M; Katafuchi R; Hashiguchi A; Kimura K; Matsuo S; Tomino Y;
J Nephrol; 2013; 26(2):350-7. PubMed ID: 22684645
[TBL] [Abstract][Full Text] [Related]
17. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
Li S; Li JP
Trials; 2020 Jan; 21(1):31. PubMed ID: 31907076
[TBL] [Abstract][Full Text] [Related]
18. IgA Nephropathy in Children: A Multicenter Study in Poland.
Mizerska-Wasiak M; Turczyn A; Such A; Cichoń-Kawa K; Małdyk J; Miklaszewska M; Pietrzyk J; Rybi-Szumińska A; Wasilewska A; Firszt-Adamczyk A; Stankiewicz R; Szczepańska M; Bieniaś B; Zajączkowska M; Pukajło-Marczyk A; Zwolińska D; Siniewicz-Luzeńczyk K; Tkaczyk M; Gadomska-Prokop K; Grenda R; Demkow U; Pańczyk-Tomaszewska M
Adv Exp Med Biol; 2016; 952():75-84. PubMed ID: 27573641
[TBL] [Abstract][Full Text] [Related]
19. Histopathologic features aid in predicting risk for progression of IgA nephropathy.
Walsh M; Sar A; Lee D; Yilmaz S; Benediktsson H; Manns B; Hemmelgarn B
Clin J Am Soc Nephrol; 2010 Mar; 5(3):425-30. PubMed ID: 20089495
[TBL] [Abstract][Full Text] [Related]
20. Long-term renal survival and undetected risk factors of IgA nephropathy in Chinese children-a retrospective 1243 cases analysis from single centre experience.
Wu H; Fang X; Xia Z; Gao C; Peng Y; Li X; Zhang P; Kuang Q; Wang R; Wang M
J Nephrol; 2020 Dec; 33(6):1263-1273. PubMed ID: 32507961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]